Furthermore, we found that MLL-ALL cells resistant to RK-20449 treatment were dependent on the anti-apoptotic B-cell lymphoma (BCL-2) protein for their survival and they could be eliminated from the MLL-ALL engrafted mice by additional inhibition of BCL-2 with ABT-199. The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.